Adrenal atrophy epidemiology and demographics

Adrenal atrophy Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Adrenal atrophy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Adrenal atrophy epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Adrenal atrophy epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Adrenal atrophy epidemiology and demographics
CDC on Adrenal atrophy epidemiology and demographics
Adrenal atrophy epidemiology and demographics in the news
Blogs on Adrenal atrophy epidemiology and demographics
Directions to Hospitals Treating Adrenal atrophy
Risk calculators and risk factors for Adrenal atrophy epidemiology and demographics

Incidence

It is estimated that the incidence of the disease is 4.4 to 6 new cases per million population, annually.

References

Prevalence

The prevalence of primary adrenal atrophy is estimated to be 93 to 144 cases per million population. In addition, secondary adrenal atrophy is more common with estimated prevalence of 150 to 280 cases per million population. Secondary adrenal atrophy is more common among women but is mainly diagnosed in their 60s.

Generally, Adrenal atrophy is more prevalent in women and may occur in any age but the clinical manifestations mainly occur in 30s to 50s.